Mainstreaming Addiction Treatment Act of 2021
Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.
Mainstreaming Addiction Treatment Act of 2021
This bill removes the requirement that a health care practitioner apply for a separate waiver through the Drug Enforcement Administration (DEA) to dispense certain narcotic drugs (e.g., buprenorphine) for maintenance or detoxification treatment (i.e., substance use disorder treatment).
Further, a community health aide or community health practitioner may dispense certain narcotic drugs for maintenance or detoxification treatment without registering with the DEA if the drug is prescribed by a health care practitioner through telemedicine. It preempts state laws related to licensure for this activity.
The bill also directs the Substance Abuse and Mental Health Services Administration to conduct a national campaign to educate health care practitioners and encourage them to integrate substance use disorder treatment into their practices.
Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
- Introduced in House Formatted Text PDF Formatted XML
Cite this page
U.S. Congress. (2026). H.R. 1384: Mainstreaming Addiction Treatment Act of 2021. 117th Congress. Open America. https://openamerica.io/bill/117-HR-1384/
"H.R. 1384: Mainstreaming Addiction Treatment Act of 2021." 117th Congress, 2026, Open America, https://openamerica.io/bill/117-HR-1384/.
H.R. 1384, 117th Cong. (2026), https://openamerica.io/bill/117-HR-1384/.
[H.R. 1384: Mainstreaming Addiction Treatment Act of 2021](https://openamerica.io/bill/117-HR-1384/)